Alberto Carmona‐Bayonas

Author

Hospital General Universitario Morales Meseguer ORCID

Also Known As

A Carmona, A Carmona Bayonas, A Carmona-Bayonas, A Custodio, A. Carmona, A. Carmona Bayonas, A. Carmona-Bayonas, A. Viúdez, AGAMENON study group, Alberto Carmona

297

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Hospital General Universitario Morales Meseguer Hospital Universitario Central de Asturias Hospital Universitario La Paz Hospital Universitario de Canarias Universitat de Barcelona

About

Alberto Carmona‐Bayonas is an author at Hospital General Universitario Morales Meseguer specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	36	1.2K
2	Health Sciences	6	6	110
3	Public Health	6	6	177
4	Nursing	3	3	89
5	Education	1	1	64

Alberto Carmona‐Bayonas

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score) Frédéric Bigot, Eduardo Castañón, Capucine Baldini, European Journal of Cancer Prognostic EvaluationAutoimmune DiseaseImmunotherapy PhaseImmunodeficienciesPrognosis	2017	215
Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu, Journal of Clinical Oncology	2015	156
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE) Barbara Nuñez-Valdovinos, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, The Oncologist	2018	90
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients Alberto Carmona‐Bayonas, J Gómez, Enrique González‐Billalabeitia, British Journal of Cancer	2011	79
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Ángela Lamarca, Journal of Clinical Oncology	2019	69
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Carme Font, Alberto Carmona‐Bayonas, Carmen Beato, European Respiratory Journal	2016	66
Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic Berta Obispo, Patricia Cruz‐Castellanos, Paula Jiménez‐Fonseca, Supportive Care in Cancer Psychological Co-morbiditiesAdvanced CancerPsychiatryMood SymptomCovid-19 Pandemic	2022	66
The mediating role of spirituality (meaning, peace, faith) between psychological distress and mental adjustment in cancer patients Paula Jiménez‐Fonseca, Urbano Lorenzo‐Seva, Pere J. Ferrando, Supportive Care in Cancer Mental AdjustmentPsychiatryReligion StudiesSpiritual DevelopmentMeditation	2017	64
Effects of pessimism, depression, fatigue, and pain on functional health-related quality of life in patients with resected non-advanced breast cancer Caterina Calderón, Alberto Carmona‐Bayonas, Raquel Hernández, The Breast Quality Of LifeLife SatisfactionLife AssessmentPsychiatryDepression	2019	61
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Isabel Echavarría, European Journal of Surgical Oncology Surgical OncologyEsophagusEsophageal CancerAgamenon National RegistryGastrointestinal Oncology	2018	59

Page 1